Skip to content

Aerobic Versus Resistance Exercises on Insulin Sensitivity in Obese Patients

Aerobic Versus Resistance Exercises on Insulin Sensitivity in Obese Patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06772857
Enrollment
3
Registered
2025-01-14
Start date
2024-07-18
Completion date
2025-01-30
Last updated
2025-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin Sensitivity/Resistance

Brief summary

The purpose of study is to compare the effect of different exercise modes on insulin resistance and body composition in obese patients.

Detailed description

The global epidemic of obesity becomes a major healthy, social, and economical burden.Indeed, it has been well established that obesity directly increases cardio metabolic risk by altering the insulin sensibility. Moreover, obesity causes additional health problems as it is closely associated with the development and progression of coronary heart disease. According to the World Health Organization (WHO), Egypt ranks 18th with the highest prevalence of obesity worldwide.( Global Obesity Levels,2020) Deaths attributable to non-communicable diseases represent about 71% of the total mortality burden .(World Health Organization,2021) Lack of exercise and sedentary behaviour (prolonged sitting) are major risk factors for insulin resistance The prevalence of obesity has increased in adults in Egypt to reach about 40% according to 100million health survey (2019) compared to the 36% estimate of 2017 STEPwise survey . This review presents established knowledge on the effects of physical activity (PA) on whole-body insulin sensitivity (SI) and body composition . 1. Sixty obese prediabetic patients from both sexes with ages ranging from 30 to 40 years old. 2. Their body mass index will be ranged from 30 to 34.9 kg/m2. 3. They have insulin resistance assessed by the homeostasis model assessment for insulin resistance (HOMAIR) Levels above 1.9 4. Their blood glucose level will be ranged from 100 to 125 mg/dL (5.6-6.9 mmol/l) 5. They will receive the same medical and diet regimen in addition to instructions not to change their physical activity during the study. Study group A (20 patients):will receive aerobic exercise training in addition to medical and diet regimen. This mode of exercise training will be applied 3 times/week for six weeks. Study group B (20 patients): will receive resistance exercise training in addition to medical and diet regimen. This mode of exercise training will be applied 3 times/week for six weeks. Control group C (20 patients): will receive medical and diet regimen only for six weeks. The patients will be instructed not to change their physical activity during the study.

Interventions

DRUGMetformin

Metformin is a drug used to manage blood glucose levels. It improves insulin sensitivity and reduces glucose production in the liver. This regimen will be provided to all study groups (A, B, and C) in combination with the respective interventions described for each group. Participants are instructed not to change their physical activity during the study.

Sponsors

National Police Hospital
CollaboratorOTHER_GOV
Cairo University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Caregiver)

Masking description

Study group A (20 patients):will receive aerobic exercise training in addition to medical and diet regimen. This mode of exercise training will be applied 3 times/week for six weeks. Study group B (20 patients): will receive resistance exercise training in addition to medical and diet regimen. This mode of exercise training will be applied 3 times/week for six weeks. Control group C (20 patients): will receive medical and diet regimen only for six weeks. The patients will be instructed not to change their physical activity during the study.

Intervention model description

The purpose of study is to compare the effect of different exercise modes on insulin resistance and body composition in obese patients

Eligibility

Sex/Gender
ALL
Age
30 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Sixty obese prediabetic patients from both sexes with ages ranging from 30 to 40 years old. * Body mass index (BMI) ranging from 30 to 34.9 kg/m². * Insulin resistance as assessed by the homeostasis model assessment for insulin resistance (HOMA-IR) levels above 1.9. * Blood glucose levels ranging from 100 to 125 mg/dL (5.6-6.9 mmol/L). * Patients will receive the same medical and diet regimen, with instructions not to change their physical activity during the study. * HbA1c levels between 6.0% and 6.5%, indicating high risk for diabetes and possible consideration for prevention interventions.

Exclusion criteria

* Uncontrolled diabetes. * Uncontrolled hypertension. * Cardiovascular disease. * Respiratory disease. * Hepatic disease. * Severe life-limiting illness (e.g., cancer). * Use of weight loss medications. * Orthopedic or neurological disorders that limit exercise participation. * Endocrine disorders. * Kidney disease.

Design outcomes

Primary

MeasureTime frameDescription
Change in Insulin Resistance Between Different Exercise Modes in Obese Patients3monthsThe change in insulin resistance will be assessed using the HOMA-IR index in obese patients after different exercise interventions (aerobic vs resistance) compared to baseline. The HOMA-IR index will be calculated based on fasting blood glucose and fasting insulin levels, which are widely accepted measures of insulin resistance.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026